Anthony Thomas Machi, MD
Pain Management · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Machi’s office at (650) 723-4000 to ask if they take your plan before you enroll.
State licence records
1 licence
- Texas Q2585Physician License · since 2014 · expires 2025-02-28Cancelled By RequestNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$24,041
Medicare paid this office $24,041 for 167 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 49 | $6,536 | $101 |
| New patient visit (60+ min) | 24 | $4,234 | $176 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $3,316 | $71 |
| Injection of trigger points, 3 or more muscles | 12 | $638 | $38 |
Who their Medicare patients are
167 Original Medicare patients in 2024. Average age 72 · Under 65 13% · 85 and older 10% · Women 62% · Also on Medicaid 29% · Health risk score 1.50. Above the middle of the specialty; the typical pain management clinician is at 1.38.
Conditions among them: High blood pressure 74% · Depression 39% · Coronary heart disease 32% · Diabetes 29% · Chronic kidney disease 28% · Atrial fibrillation 20% · Cancer 19% · Heart failure 18% · COPD 16% · Dementia 8% · Stroke 7%.
The office billed $298,720, Medicare allowed $30,174 and paid $24,041; for 253 services of 42 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 167 | 253 | 72 | 1.50 | $298,720 | $24,041 |
| 2023 | 107 | 135 | 71 | 2.06 | $164,314 | $13,054 |
| 2022 | 195 | 330 | 71 | 1.70 | $263,531 | $23,492 |
| 2021 | 227 | 412 | 70 | 1.92 | $302,961 | $26,487 |
| 2020 | 307 | 456 | 70 | 2.06 | $417,313 | $34,972 |
| 2019 | 403 | 548 | 70 | 2.69 | $546,216 | $44,810 |
| 2018 | 390 | 527 | 70 | 2.35 | $498,279 | $40,623 |
| 2017 | 391 | 569 | 70 | 1.77 | $507,226 | $43,197 |
| 2016 | 236 | 394 | 70 | 1.79 | $368,420 | $32,367 |
| 2015 | 183 | 270 | 67 | 1.92 | $248,048 | $21,350 |
| 2014 | 161 | 188 | 70 | 1.83 | $190,540 | $35,552 |
| 2013 | 146 | 189 | 72 | 1.68 | $191,634 | $31,371 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 8 services
| Daily hospital management of continuous spinal drug administration | 23 | $1,659 | $50 |
| Ultrasonic guidance for needle placement | 67 | $1,652 | $24 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 31 | $1,047 | $33 |
| Insertion of tube and injection of substance into middle or upper spine canal | 11 | $778 | $71 |
| Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | 13 | $712 | $55 |
| Injection of anesthetic agent and/or steroid into arm nerve bundle (brachial plexus) | 13 | $653 | $50 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 15 | $640 | $40 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 12 | $401 | $33 |
2021: 8 services
| Ultrasonic guidance for needle placement | 93 | $2,293 | $24 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 48 | $1,746 | $36 |
| Daily hospital management of continuous spinal drug administration | 17 | $1,544 | $51 |
| Injection of anesthetic agent and/or steroid into arm nerve bundle (brachial plexus) | 22 | $1,100 | $50 |
| Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | 18 | $1,028 | $54 |
| Anesthesia for other procedure on large bowel using an endoscope | 11 | $629 | $57 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 16 | $599 | $32 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 11 | $466 | $42 |
2020: 12 services
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 29 | $1,941 | $67 |
| Ultrasonic guidance for needle placement | 61 | $1,595 | $26 |
| Daily hospital management of continuous spinal drug administration | 18 | $1,439 | $51 |
| Anesthesia for other procedure on lower leg, ankle, and foot bones | 13 | $1,242 | $96 |
| Anesthesia for other procedure on large bowel using an endoscope | 16 | $999 | $62 |
| Injection of substance into lower spine canal | 14 | $974 | $70 |
| Anesthesia for procedure on small and large bowel using an endoscope | 12 | $918 | $77 |
| Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | 15 | $859 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $797 | $32 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 20 | $770 | $38 |
| Injection of anesthetic agent and/or steroid into arm nerve bundle (brachial plexus) | 11 | $629 | $52 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 11 | $457 | $33 |
2019: 14 services
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 60 | $4,319 | $71 |
| Anesthesia for kidney transplant | 13 | $3,640 | $280 |
| Anesthesia for other procedure on large bowel using an endoscope | 52 | $3,261 | $63 |
| Anesthesia for procedure on small and large bowel using an endoscope | 24 | $1,861 | $78 |
| Ultrasonic guidance for needle placement | 65 | $1,686 | $26 |
| Anesthesia for other procedure on lower leg, ankle, and foot bones | 11 | $1,173 | $107 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 23 | $1,049 | $46 |
| Continuous infusion of anesthetic agent and/or steroid into arm nerve bundle through catheter | 12 | $835 | $64 |
| Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | 13 | $739 | $57 |
| Continuous infusion of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) through catheter | 11 | $707 | $64 |
| Daily hospital management of continuous spinal drug administration | 11 | $679 | $52 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $658 | $31 |
| Injection of anesthetic agent and/or steroid into arm nerve bundle (brachial plexus) | 12 | $578 | $48 |
| Insertion of artery tube for blood sampling or infusion through skin | 12 | $433 | $36 |
2018: 10 services
| Anesthesia for other procedure on esophagus, stomach, or upper small bowel using an endoscope | 77 | $5,304 | $67 |
| Anesthesia for other procedure on large bowel using an endoscope | 54 | $3,519 | $65 |
| Anesthesia for procedure on small and large bowel using an endoscope | 22 | $1,843 | $84 |
| Ultrasonic guidance for needle placement | 50 | $1,331 | $26 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 23 | $1,021 | $44 |
| Daily hospital management of continuous spinal drug administration | 17 | $989 | $52 |
| Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | 17 | $979 | $58 |
| Anesthesia for exam of colon using an endoscope | 14 | $869 | $62 |
| Anesthesia for other procedure on large bowel using an endoscope | 13 | $855 | $66 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $532 | $31 |
2017: 11 services
| Anesthesia for procedure on gastrointestinal tract using an endoscope | 73 | $5,148 | $71 |
| Anesthesia for procedure on lower intestine using an endoscope | 35 | $2,589 | $72 |
| Ultrasonic guidance for needle placement | 85 | $2,228 | $26 |
| Continuous infusion of anesthetic agent and/or steroid into arm nerve bundle through catheter | 25 | $1,589 | $64 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 31 | $1,522 | $49 |
| Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | 24 | $1,428 | $59 |
| Daily hospital management of continuous spinal drug administration | 19 | $1,140 | $52 |
| Anesthesia for lens surgery | 17 | $1,090 | $64 |
| Injection of anesthetic agent and/or steroid into arm nerve bundle (brachial plexus) | 14 | $706 | $47 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $656 | $31 |
| Insertion of artery tube for blood sampling or infusion through skin | 11 | $431 | $39 |
2016: 10 services
| Anesthesia for open or endoscopic total shoulder joint replacement | 14 | $2,595 | $185 |
| Anesthesia for procedure for total knee joint replacement | 13 | $1,980 | $152 |
| Ultrasonic guidance for needle placement | 71 | $1,866 | $26 |
| Injection of anesthetic agent and/or steroid into thigh nerve (femoral nerve) | 30 | $1,577 | $53 |
| Anesthesia for procedure on lower intestine using an endoscope | 17 | $1,248 | $73 |
| Daily hospital management of continuous spinal drug administration | 12 | $1,036 | $52 |
| Continuous infusion of anesthetic agent and/or steroid into arm nerve bundle through catheter | 16 | $984 | $62 |
| Anesthesia for procedure on gastrointestinal tract using an endoscope | 12 | $947 | $79 |
| Injection of local anesthetic for abdominal wall pain control on both sides using imaging guidance | 13 | $838 | $64 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $468 | $31 |
2015: 5 services
| Anesthesia for procedure on lower intestine using an endoscope | 20 | $1,548 | $77 |
| Anesthesia for procedure on gastrointestinal tract using an endoscope | 17 | $1,341 | $79 |
| Daily hospital management of continuous spinal drug administration | 15 | $1,057 | $53 |
| Ultrasonic guidance for needle placement | 36 | $964 | $26 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 13 | $484 | $25 |
2014: 3 services
| Anesthesia for lens surgery | 21 | $2,577 | $123 |
| Anesthesia for electroshock therapy | 18 | $2,444 | $98 |
| Anesthesia for other procedure on skin of arms, legs, and front body | 11 | $1,541 | $140 |
2013: 3 services
| Anesthesia for other procedure on skin of arms, legs, and front body | 12 | $1,765 | $147 |
| Insertion of artery tube for blood sampling or infusion through skin | 17 | $707 | $42 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $400 | $31 |
Drugs they prescribed that Part D paid
$1,407
Pharmacies billed $1,407 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 17% of their Part D prescriptions (11 of 64) in 2024. At or below the middle of the specialty; the typical pain management clinician is at 44%.
63 generic and fewer than 11 brand-name prescriptions · $1,407 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Duloxetine | 11 | $380 | $21 |
Year by year
| 2024 | 64 | 35 | 17% (11) | None | $1,407 |
| 2023 | 14 | None | None | 0% | $435 |
| 2021 | 60 | None | 0% (0) | 18% | $1,412 |
| 2020 | 71 | None | 0% (0) | 17% | $879 |
| 2019 | 41 | None | 0% (0) | 29% | $1,320 |
| 2018 | 49 | None | 0% (0) | 29% | $616 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2021: 2 drugs
| Methylphenidate | 11 | $488 | $44 |
| Alprazolam | 11 | $183 | $17 |
2020: 5 drugs
| Bupropion Xl | 12 | $356 | $30 |
| Methylphenidate | 13 | $206 | $16 |
| Clonazepam | 12 | $83 | $7 |
| Alprazolam | 12 | $80 | $7 |
| Escitalopram | 13 | $67 | $5 |
2019: 3 drugs
| Escitalopram | 12 | $300 | $25 |
| Clonazepam | 12 | $228 | $19 |
| Alprazolam | 12 | $221 | $18 |
2018: 3 drugs
| Escitalopram | 14 | $194 | $14 |
| Alprazolam | 14 | $162 | $12 |
| Clonazepam | 13 | $159 | $12 |
Money from drug and device companies
$1,584 in 2025
| 2025 | 4 | 10 | None | $1,584 |
| 2024 | 7 | 11 | None | $1,168 |
| 2023 | 4 | 5 | None | $576 |
| 2022 | 1 | 1 | None | $64 |
| 2021 | 1 | 1 | None | $121 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Proclaim | $1,055 | 6 payments
|
| Biotronik Nro | Prospera | $389 | 2 payments
|
| Vertex Pharmaceuticals | Journavx | $122 | 1 payment
|
| Vericel | Maci | $18 | 1 payment
|
See all 10 published payments
| Vericel | Meals · 2025-11-18 | Maci | $18 |
| Abbott Laboratories | Meals · 2025-10-22 | Proclaim | $56 |
| Abbott Laboratories | Travel · 2025-09-26 | Proclaim | $94 |
| Abbott Laboratories | Travel · 2025-09-26 | Proclaim | $168 |
| Abbott Laboratories | Travel · 2025-09-26 | Proclaim | $463 |
| Biotronik Nro | Meals · 2025-09-16 | Prospera | $172 |
| Vertex Pharmaceuticals | Meals · 2025-07-10 | Journavx | $122 |
| Abbott Laboratories | Travel · 2025-06-20 | Proclaim | $266 |
| Abbott Laboratories | Travel · 2025-06-20 | Proclaim | $9 |
| Biotronik Nro | Meals · 2025-02-26 | Prospera | $218 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,168
| Biotronik Nro | Prospera | $376 | 3 payments
|
| Medtronic | Intellis Adaptivestim | $250 | 2 payments
|
| Nalu Medical | Nalu Neurostimulation System | $155 | 1 payment
|
| Painteq | Painteq | $122 | 1 payment
|
| Vertos Medical | Mild Device Kit | $116 | 2 payments
|
| SPR Therapeutics | Sprint Pns System | $101 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Relistor | $48 | 1 payment
|
2023: $576
| Vertos Medical | Mild Device Kit | $307 | 2 payments
|
| Nevro | Senza | $136 | 1 payment
|
| SPR Therapeutics | Sprint Pns System | $116 | 1 payment
|
| Boston Scientific | None | $17 | 1 payment
|
2022: $64
| Nevro | Omnia | $64 | 1 payment
|
2021: $121
| Pacira Pharmaceuticals | Exparel | $121 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1518123348
- Licence
- CA A11152, MT MED-PHYS-LIC-34409, TX Q2585Texas Q2585: Cancelled By Request
- Trained
- University of Wisconsin School of Medicine, 2007
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207LP2900X (207LP2900X); Federal specialty code 207L00000X (207L00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-07-31
- NPI last updated
- 2024-10-10
- NPI record certified
- 2024-10-10
This is when the NPI record was last certified, not a medical board exam.